Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Rafael F. Sequeira"'
Publikováno v:
Case Reports in Cardiology, Vol 2013 (2013)
Coronary artery spasm has been reported during adenosine stress testing. Herein, we describe a transient ST-segment elevation following adenosine therapy for supraventricular tachycardia. A 38-year-old male presented to the emergency department with
Externí odkaz:
https://doaj.org/article/5909f46f741c4f3db6abf95a79b01772
Autor:
Apurva Badheka, Nileshkumar J. Patel, Rafael F. Sequeira, Joseph Esterson, George R. Marzouka
Publikováno v:
Echocardiography. 29:E166-E168
There have only been a few cases reported of right ventricular outflow tract obstruction secondary to diffuse large B-cell lymphomas. Mediastinal masses rarely cause extrinsic compression of the heart resulting in hemodynamically significant obstruct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5145e80067506660d43553df47ffeb98
https://doi.org/10.1111/j.1540-8175.2012.01683.x
https://doi.org/10.1111/j.1540-8175.2012.01683.x
Autor:
Kushagra Katariya, Stephen Mallon, Hooshang Bolooki, Si M. Pham, X S Qi, Javier León Jiménez, R J Kaplon, Rafael F. Sequeira, P C Lee, Eugene J. Bauerlein, Tomas A. Salerno, A F Loo, Eliot Rosenkranz
Publikováno v:
Transplantation Proceedings. 34:1839-1842
Aim: The nephrotoxicity associated with calcineurin-inhibitors is dose dependent. The goal of this study is to determine whether a combination of tacrolimus and sirolimus will allow us to reduce the level of tacrolimus in heart transplant recipients,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5dd04d7658061eeb76a65205fef8166
https://doi.org/10.1016/s0041-1345(02)03098-1
https://doi.org/10.1016/s0041-1345(02)03098-1
Autor:
Catherine C Bryson, Sukh Mehta, Hamid Ikram, Rafael F. Sequeira, Eckart Fleck, Dougal McClean, Alan Niederman, Benoit Coutu, Chunlin Qian, Steven N. Singh, James J. Hanyok, Michel Komajda, Peter Hanrath, Michel F. Rousseau, J.Thomas Heywood
Publikováno v:
Journal of the American College of Cardiology. 39(12):2034-2041
OBJECTIVES We investigated the acute and long-term hemodynamic and neurohumoral effects of the vasopeptidase inhibitor omapatrilat in human heart failure. BACKGROUND Angiotensin-converting enzyme (ACE) inhibition constitutes a major advance in the tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1fc52539dbb59f1f59e9f6704da787f
Autor:
Matthew Bacchetta, Corey K. Goldman, John R. Laird, Nicolas Chronos, Anthony J. Comerota, Kathryn A. Miller, Juha Salenius, Craig K. Kent, Richard C. Throm, Timothy D. Henry, Rafael F. Sequeira, Richard Pilsudski, Frank A. Schmieder
Publikováno v:
Journal of Vascular Surgery. 35:930-936
Objective: The objective of this study was to evaluate the safety and tolerance of increasing single and repeated (n = 2) doses of intramuscular naked plasmid DNA encoding for fibroblast growth factor (FGF) type 1 (NV1FGF) administered to patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9e9762cfeaf07e20123b11dbbe30f1d
https://doi.org/10.1067/mva.2002.123677
https://doi.org/10.1067/mva.2002.123677
Autor:
Robert P. Giugliano, Sylvain B. Nicolas, Martin J. Frey, Timothy D. Henry, Bradford K. Jensen, Robert J. Wise, Eugene Braunwald, Rafael F. Sequeira, Lisa K. Jennings, Robert N. Piana, Carolyn H. McCabe, Jean Francois Tamby
Publikováno v:
American Heart Journal. 140:81-92
Background RPR 109891 is a modified tetrapeptide glycoprotein IIb/IIIa inhibitor available in intravenous and oral formulations. Two phase II dose-ranging studies were performed to investigate pharmacodynamics and safety in acute coronary syndromes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1138604898eda90dc63fd3b3d25cd975
https://doi.org/10.1067/mhj.2000.107172
https://doi.org/10.1067/mhj.2000.107172
Autor:
Sabina A. Murphy, C. Michael Gibson, A.A.Jennifer Adgey, NL Fox, Rafael F. Sequeira, Marc J. Schweiger, Gilles Grollier, W. Douglas Weaver, Christopher P. Cannon, Eugene Braunwald, S Berioli, Frans Van de Werf
Publikováno v:
The American Journal of Cardiology. 84:976-980
Fixed doses of thrombolytic agents are generally administered to patients of varying body weights, and the dose-response relation may be confounded by the variability in patient weight. We hypothesized that higher doses of TNK-tissue plasminogen acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66b695eb16a28e9299dda4cf334ebf24
https://doi.org/10.1016/s0002-9149(99)00483-x
https://doi.org/10.1016/s0002-9149(99)00483-x
Autor:
Robert M. Greene, Martin J. Frey, Eugene Braunwald, Robert P. Giugliano, Susan J. Marble, Rafael F. Sequeira, Sabina A. Murphy, Christopher P. Cannon, Marc J. Schweiger, Magdi Ghali, Ian B. A. Menown, K. Ryan, C. Michael Gibson, Frans Van de Werf, Elliott M. Antman
Publikováno v:
Journal of the American College of Cardiology. 34(5):1403-1412
OBJECTIVESThis study evaluated the determinants of coronary blood flow following thrombolytic administration in a large cohort of patients.BACKGROUNDTighter residual stenoses following thrombolysis have been associated with slower coronary blood flow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a21b6db27324ccb787ee8f37e950a0
TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction
Autor:
Richard M. Steingart, Robert P. Giugliano, Eugene Braunwald, Martin J. Frey, Christopher P. Cannon, C. Michael Gibson, Frans Van de Werf, Hiltrud S. Mueller, Gilles Grollier, Carolyn H. McCabe, Marc J. Schweiger, A.A.Jennifer Adgey, W. Douglas Weaver, Rafael F. Sequeira
Publikováno v:
Circulation. 98:2805-2814
Background —Bolus thrombolytic therapy is a simplified means of administering thrombolysis that facilitates rapid time to treatment. TNK-tissue plasminogen activator (TNK-tPA) is a highly fibrin-specific single-bolus thrombolytic agent. Methods and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0193d6f24422ea7cfa0b1e3d09fa70f9
https://doi.org/10.1161/01.cir.98.25.2805
https://doi.org/10.1161/01.cir.98.25.2805
Autor:
Christopher P. Cannon, Peter J. Sharis, Eugene Braunwald, Robert M. Greene, Daniel J. Diver, Marc J. Schweiger, Rebecca Perritt, Prediman K. Shah, Carolyn H. McCabe, Rafael F. Sequeira, W. Kenneth Poole
Publikováno v:
The American Journal of Cardiology. 80:696-699
Although the use of composite end points in clinical trials has increased in recent years, few data are available on the validity of such an approach. In the Thrombolysis In Myocardial Infarction (TIMI) 4 and 5 trials, we set out to validate prospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a6359bdbd8ec1a1e1f121656c8b014a
https://doi.org/10.1016/s0002-9149(97)00497-9
https://doi.org/10.1016/s0002-9149(97)00497-9